Search

everythinglearnresearchcommunity

for

Search:↓

Combining stem cell media with laser or microneedling can effectively regrow hair in alopecia areata.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

The treatment is a safe and effective option for hair regrowth in patchy alopecia areata.

People with autism are more likely to develop alopecia areata than those without autism.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Alopecia areata is more common in women, often appears as patchy hair loss, and is usually treated with steroid injections and minoxidil.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata is more common in males, often appears as patchy hair loss, and is strongly linked to anemia.

Alopecia areata may be linked to kidney issues, but more research is needed.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Alopecia causes patchy hair loss and can be diagnosed with new techniques; treatments like strong creams and contact immunotherapy can help.